InfuSystem Holdings, Inc. (NYSE:INFU) CEO Richard Dilorio Sells 5,398 Shares

InfuSystem Holdings, Inc. (NYSE:INFU) CEO Richard Dilorio sold 5,398 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $8.87, for a total transaction of $47,880.26. Following the completion of the sale, the chief executive officer now owns 416,659 shares in the company, valued at $3,695,765.33. This represents a 1.28 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Richard Dilorio also recently made the following trade(s):

• On Monday, November 25th, Richard Dilorio sold 20,000 shares of InfuSystem stock. The stock was sold at an average price of $9.32, for a total value of $186,400.00.

InfuSystem Stock Down 1.1 %

Shares of INFU traded down $0.10 during midday trading on Wednesday, reaching $8.85. 39,965 shares of the stock were exchanged, compared to its average volume of 60,063. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. InfuSystem Holdings, Inc. has a twelve month low of $5.74 and a twelve month high of $10.99. The stock has a market capitalization of $188.15 million, a P/E ratio of 147.52 and a beta of 1.45. The firm has a 50 day moving average of $7.29.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on INFU. B. Riley began coverage on shares of InfuSystem in a research note on Thursday, September 26th. They set a “buy” rating and a $13.00 price target for the company. StockNews.com raised shares of InfuSystem from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 8th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in shares of InfuSystem by 1.7% during the first quarter. Vanguard Group Inc. now owns 1,083,730 shares of the company’s stock worth $9,288,000 after purchasing an additional 18,432 shares during the last quarter. Sequoia Financial Advisors LLC bought a new stake in shares of InfuSystem during the second quarter worth about $272,000. ARS Investment Partners LLC grew its holdings in shares of InfuSystem by 11.4% during the second quarter. ARS Investment Partners LLC now owns 33,510 shares of the company’s stock worth $229,000 after purchasing an additional 3,422 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of InfuSystem by 6.1% during the second quarter. Bank of New York Mellon Corp now owns 93,899 shares of the company’s stock worth $641,000 after purchasing an additional 5,391 shares during the last quarter. Finally, Panagora Asset Management Inc. bought a new stake in shares of InfuSystem during the second quarter worth about $208,000. Institutional investors own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.